Skip to content

Chapter 8 of 8

Quality Control, CLIA, and Professional Practice

Laboratory quality is regulated in the United States by the Clinical Laboratory Improvement Amendments (CLIA), which establish standards to ensure accurate, reliable, and timely patient testing. CLIA classifies tests into three categories based on complexity: waived tests, which are simple with low risk of error and include devices such as glucometers and urine dipsticks; moderate complexity tests; and high complexity tests. Within every laboratory, quality control (QC) involves testing known control samples alongside patient specimens to verify the accuracy and precision of test systems. Quality assurance (QA) is a broader concept encompassing the entire testing process to ensure quality outcomes. External proficiency testing (PT) programs, in which laboratories analyze unknown samples and compare their results with those of peer laboratories, further verify accuracy. Tools such as Levey-Jennings charts graphically track QC results over time, and Westgard rules, including the 1-3s rule, help identify random or systematic errors. A critical or panic value is a test result so abnormal that it is considered life-threatening and requires immediate notification of the ordering provider.

The total testing process is divided into three phases. The preanalytical phase includes everything that happens before the actual analysis: test ordering, patient identification, specimen collection, labeling, and transport. The analytical phase encompasses the testing of the specimen itself, while the postanalytical phase involves result reporting, interpretation, and delivery of results to the provider. The majority of laboratory errors occur during the preanalytical phase, often due to mislabeling, hemolysis, wrong tube type, or improper collection technique. Emphasizing careful technique during collection and handling is therefore essential for patient safety.

Phlebotomists must also understand the medical and legal framework governing their practice. Common medical terminology includes hemo or hema, meaning blood; the suffix emia, referring to a condition of the blood, as in anemia or hyperglycemia; antecubital, referring to the area in front of the elbow; lipemia, the presence of excess lipids giving serum a milky appearance; icterus, yellow discoloration due to elevated bilirubin; and hemolyzed, describing a specimen with ruptured red blood cells. The term phlebotomy itself literally means "vein cutting," from phlebo (vein) and tomy (incision). Iatrogenic describes a condition caused by medical treatment, syncope means fainting, hematoma refers to a localized collection of blood outside a vessel, nosocomial relates to infections acquired in a healthcare setting, and aliquot refers to a measured portion of a larger specimen used for a specific test.

Legal and ethical concepts are equally important. The Health Insurance Portability and Accountability Act (HIPAA) protects patient privacy and confidentiality of health information, and any unauthorized disclosure of protected health information (PHI) constitutes a breach of confidentiality. Informed consent is the patient's voluntary agreement to undergo the blood draw based on adequate information, and patients also have the right of informed refusal. Assault is the threat or attempt to touch a patient without consent, while battery is the unauthorized physical contact itself. Negligence is the failure to act with the standard of care a reasonably prudent person would exercise, and the four elements required to prove negligence are duty, dereliction or breach of that duty, direct cause, and damages. The statute of limitations defines the time period during which a lawsuit may be filed. Phlebotomists must practice within their defined scope of practice, properly document their actions, complete incident reports following any adverse event, and remember that proper documentation provides critical legal evidence that procedures were performed according to standard. Introducing oneself to the patient and explaining the procedure establishes trust, ensures informed consent, reduces anxiety, and supports both the professional and legal standards of care.

All chapters
  1. 1Order of Draw and Tube Additives
  2. 2Venipuncture Anatomy and Site Selection
  3. 3Venipuncture Technique and Equipment
  4. 4Capillary and Dermal Puncture
  5. 5Patient Identification and Specimen Handling
  6. 6Complications and Adverse Events
  7. 7Infection Control, OSHA, and Safety
  8. 8Quality Control, CLIA, and Professional Practice

Drill it

Reading is not remembering. These come from the Phlebotomy Certification Nha Ascp deck:

Q

What is the correct order of draw for venipuncture (ETS)?

1. Blood cultures (yellow SPS)2. Light blue (sodium citrate)3. Serum tubes (red/gold, SST)4. Green (heparin)5. Lavender (EDTA)6. Gray (sodium fluoride)

Q

Why must the order of draw be followed?

To prevent cross-contamination of additives between tubes, which can alter test results.

Q

Which tube is drawn first in the order of draw?

Blood culture bottles/tubes (yellow SPS) to maintain sterility.

Q

Which tube is drawn immediately after blood cultures?

The light blue sodium citrate tube (coagulation studies).